-
Je něco špatně v tomto záznamu ?
The deletion of AQP4 and TRPV4 affects astrocyte swelling/volume recovery in response to ischemia-mimicking pathologies
Z. Hermanova, L. Valihrach, J. Kriska, M. Maheta, J. Tureckova, M. Kubista, M. Anderova
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2007
Free Medical Journals
od 2007
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2023-01-01
Open Access Digital Library
od 2007-01-01
Open Access Digital Library
od 2007-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2007
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Astrocytic Transient receptor potential vanilloid 4 (TRPV4) channels, together with Aquaporin 4 (AQP4), are suspected to be the key players in cellular volume regulation, and therefore may affect the development and severity of cerebral edema during ischemia. In this study, we examined astrocytic swelling/volume recovery in mice with TRPV4 and/or AQP4 deletion in response to in vitro ischemic conditions, to determine how the deletion of these channels can affect the development of cerebral edema. METHODS: We used three models of ischemia-related pathological conditions: hypoosmotic stress, hyperkalemia, and oxygenglucose deprivation (OGD), and observed their effect on astrocyte volume changes in acute brain slices of Aqp4-/-, Trpv4-/- and double knockouts. In addition, we employed single-cell RT-qPCR to assess the effect of TRPV4 and AQP4 deletion on the expression of other ion channels and transporters involved in the homeostatic functioning of astrocytes. RESULTS: Quantification of astrocyte volume changes during OGD revealed that the deletion of AQP4 reduces astrocyte swelling, while simultaneous deletion of both AQP4 and TRPV4 leads to a disruption of astrocyte volume recovery during the subsequent washout. Of note, astrocyte exposure to hypoosmotic stress or hyperkalemia revealed no differences in astrocyte swelling in the absence of AQP4, TRPV4, or both channels. Moreover, under ischemia-mimicking conditions, we identified two distinct subpopulations of astrocytes with low and high volumetric responses (LRA and HRA), and their analyses revealed that mainly HRA are affected by the deletion of AQP4, TRPV4, or both channels. Furthermore, gene expression analysis revealed reduced expression of the ion transporters KCC1 and ClC2 as well as the receptors GABAB and NMDA in Trpv4-/- mice. The deletion of AQP4 instead caused reduced expression of the serine/cysteine peptidase inhibitor Serpina3n. DISCUSSION: Thus, we showed that in AQP4 or TRPV4 knockouts, not only the specific function of these channels is affected, but also the expression of other proteins, which may modulate the ischemic cascade and thus influence the final impact of ischemia.
2nd Faculty of Medicine Charles University Prague Czechia
Department of Cellular Neurophysiology Institute of Experimental Medicine CAS Prague Czechia
Laboratory of Gene Expression Institute of Biotechnology CAS Vestec Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012763
- 003
- CZ-PrNML
- 005
- 20240726151354.0
- 007
- ta
- 008
- 240723e20240515sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fncel.2024.1393751 $2 doi
- 035 __
- $a (PubMed)38818517
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hermanova, Zuzana $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia $u Second Faculty of Medicine, Charles University, Prague, Czechia
- 245 14
- $a The deletion of AQP4 and TRPV4 affects astrocyte swelling/volume recovery in response to ischemia-mimicking pathologies / $c Z. Hermanova, L. Valihrach, J. Kriska, M. Maheta, J. Tureckova, M. Kubista, M. Anderova
- 520 9_
- $a INTRODUCTION: Astrocytic Transient receptor potential vanilloid 4 (TRPV4) channels, together with Aquaporin 4 (AQP4), are suspected to be the key players in cellular volume regulation, and therefore may affect the development and severity of cerebral edema during ischemia. In this study, we examined astrocytic swelling/volume recovery in mice with TRPV4 and/or AQP4 deletion in response to in vitro ischemic conditions, to determine how the deletion of these channels can affect the development of cerebral edema. METHODS: We used three models of ischemia-related pathological conditions: hypoosmotic stress, hyperkalemia, and oxygenglucose deprivation (OGD), and observed their effect on astrocyte volume changes in acute brain slices of Aqp4-/-, Trpv4-/- and double knockouts. In addition, we employed single-cell RT-qPCR to assess the effect of TRPV4 and AQP4 deletion on the expression of other ion channels and transporters involved in the homeostatic functioning of astrocytes. RESULTS: Quantification of astrocyte volume changes during OGD revealed that the deletion of AQP4 reduces astrocyte swelling, while simultaneous deletion of both AQP4 and TRPV4 leads to a disruption of astrocyte volume recovery during the subsequent washout. Of note, astrocyte exposure to hypoosmotic stress or hyperkalemia revealed no differences in astrocyte swelling in the absence of AQP4, TRPV4, or both channels. Moreover, under ischemia-mimicking conditions, we identified two distinct subpopulations of astrocytes with low and high volumetric responses (LRA and HRA), and their analyses revealed that mainly HRA are affected by the deletion of AQP4, TRPV4, or both channels. Furthermore, gene expression analysis revealed reduced expression of the ion transporters KCC1 and ClC2 as well as the receptors GABAB and NMDA in Trpv4-/- mice. The deletion of AQP4 instead caused reduced expression of the serine/cysteine peptidase inhibitor Serpina3n. DISCUSSION: Thus, we showed that in AQP4 or TRPV4 knockouts, not only the specific function of these channels is affected, but also the expression of other proteins, which may modulate the ischemic cascade and thus influence the final impact of ischemia.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Valihrach, Lukas $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
- 700 1_
- $a Kriska, Jan $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
- 700 1_
- $a Maheta, Mansi $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
- 700 1_
- $a Tureckova, Jana $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
- 700 1_
- $a Kubista, Mikael $u Laboratory of Gene Expression, Institute of Biotechnology CAS, Vestec, Czechia
- 700 1_
- $a Anderova, Miroslava $u Department of Cellular Neurophysiology, Institute of Experimental Medicine CAS, Prague, Czechia
- 773 0_
- $w MED00163312 $t Frontiers in cellular neuroscience $x 1662-5102 $g Roč. 18 (20240515), s. 1393751
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38818517 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151347 $b ABA008
- 999 __
- $a ok $b bmc $g 2125470 $s 1224626
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 18 $c - $d 1393751 $e 20240515 $i 1662-5102 $m Frontiers in cellular neuroscience $n Front Cell Neurosci $x MED00163312
- LZP __
- $a Pubmed-20240723